Cell Impact AB (CI) Stock Statistics & Valuation Metrics

Cell Impact AB has a market cap or net worth of kr59.88M. The enterprise value is kr110.09M.

Cell Impact AB has 696,271,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cell Impact AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Cell Impact AB is -0.92. Cell Impact AB’s PEG ratio is 0.01.

In the last 12 months, Cell Impact AB had revenue of 37.33M and earned -100.43M in profits. Earnings per share was -0.16.

In the last 12 months, operating cash flow was -61.44M and capital expenditures -22.55M, giving a free cash flow of -83.98M billion.

Cell Impact AB pays an annual dividend of ―, resulting in a dividend yield of ―

Cell Impact AB upcoming earnings date is May 14, 2025, TBA Not Confirmed.

Cell Impact AB as a current ratio of 3.03, with Debt / Equity ratio of 14.11%

In the past 12 months, Cell Impact AB has paid 85.00K in taxes.

Cell Impact AB EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Cell Impact AB has kr20.39M in cash and marketable securities with kr1.70M in debt, giving a net cash position of kr10.53M billion.

Gross margin is -164.90%, with operating margin of -265.29%, and net profit margin of -269.08%.

The average price target for Cell Impact AB is ―, which is 11.43% higher than the current price. The consensus rating is ―